(Q54782466)

3 June 2018

title

Ciprofloxacin in the treatment of urinary tract infection due to enterobacteria. (English)

1 reference

3 June 2018

main subject

urinary tract infection

1 reference

J Guibert

1

1 reference

3 June 2018

D Destrée

series ordinal

2

1 reference

3 June 2018

C Konopka

series ordinal

3

1 reference

3 June 2018

J Acar

series ordinal

4

1 reference

3 June 2018

publication date

1 April 1986

1 reference

3 June 2018

European journal of clinical microbiology

published in

1 reference

3 June 2018

volume

5

1 reference

3 June 2018

issue

2

1 reference

3 June 2018

page(s)

247-248

1 reference

3 June 2018

In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02014000

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02014000

Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02014000

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02014000

Pharmacokinetics and tissue penetration of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02014000

Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)

21 January 2018

1 reference

12 December 2020

The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin

1 reference

12 December 2020

Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)

1 reference

12 December 2020

[Clinical evaluation of cefmenoxime in urinary tract and prostatic infections]

1 reference

12 December 2020

[Clinical evaluation of azthreonam in severe urinary tract infections]

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02014000

1 reference

3 June 2018

PubMed ID

2941292

1 reference

3 June 2018